Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07459010) titled 'ACT Dad's Power: Feasibility RCT for Fathers of Children With Special Needs' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: The Hong Kong Polytechnic University
Condition:
Developmental Disabilities
Intervention:
Behavioral: VR-based ACT
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 1, 2026
Target Sample Size: 50
To know more, visit https://clinicaltrials.gov/study/NCT07459010
Published by HT Digital Conten...